Cargando…
Loss of CD96 Expression as a Marker of HIV-Specific CD8(+) T-Cell Differentiation and Dysfunction
Persistent immune activation and inflammation in people living with HIV (PLWH) are associated with immunosenescence, premature aging and increased risk of non-AIDS comorbidities, with the underlying mechanisms not fully understood. In this study, we show that downregulation of the T-cell immunoglobu...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190400/ https://www.ncbi.nlm.nih.gov/pubmed/34122431 http://dx.doi.org/10.3389/fimmu.2021.673061 |
_version_ | 1783705679830188032 |
---|---|
author | Bunet, Rémi Nayrac, Manon Ramani, Hardik Sylla, Mohamed Durand, Madeleine Chartrand-Lefebvre, Carl Routy, Jean-Pierre Landay, Alan L. Gauchat, Jean-Francois Chomont, Nicolas Ancuta, Petronela Kaufmann, Daniel E. Bernard, Nicole Tremblay, Cécile L. El-Far, Mohamed |
author_facet | Bunet, Rémi Nayrac, Manon Ramani, Hardik Sylla, Mohamed Durand, Madeleine Chartrand-Lefebvre, Carl Routy, Jean-Pierre Landay, Alan L. Gauchat, Jean-Francois Chomont, Nicolas Ancuta, Petronela Kaufmann, Daniel E. Bernard, Nicole Tremblay, Cécile L. El-Far, Mohamed |
author_sort | Bunet, Rémi |
collection | PubMed |
description | Persistent immune activation and inflammation in people living with HIV (PLWH) are associated with immunosenescence, premature aging and increased risk of non-AIDS comorbidities, with the underlying mechanisms not fully understood. In this study, we show that downregulation of the T-cell immunoglobulin receptor CD96 on CD8(+) T cells from PLWH is associated with decreased expression of the co-stimulatory receptors CD27 and CD28, higher expression of the senescence marker CD57 and accumulation of a terminally differentiated T-cell memory phenotype. In addition, we show that CD96-low CD8(+) T-cells display lower proliferative potential compared to their CD96-high counterparts and that loss of CD96 expression by HIV-specific CD8(+) T-cells is associated with a suboptimal response to HIV antigens. In conclusion, our results suggest that CD96 marks CD8(+) T-cells with competent responses to HIV and the loss of its expression might be used as a biomarker for CD8(+) T-cell senescence and dysfunction in PLWH. |
format | Online Article Text |
id | pubmed-8190400 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81904002021-06-11 Loss of CD96 Expression as a Marker of HIV-Specific CD8(+) T-Cell Differentiation and Dysfunction Bunet, Rémi Nayrac, Manon Ramani, Hardik Sylla, Mohamed Durand, Madeleine Chartrand-Lefebvre, Carl Routy, Jean-Pierre Landay, Alan L. Gauchat, Jean-Francois Chomont, Nicolas Ancuta, Petronela Kaufmann, Daniel E. Bernard, Nicole Tremblay, Cécile L. El-Far, Mohamed Front Immunol Immunology Persistent immune activation and inflammation in people living with HIV (PLWH) are associated with immunosenescence, premature aging and increased risk of non-AIDS comorbidities, with the underlying mechanisms not fully understood. In this study, we show that downregulation of the T-cell immunoglobulin receptor CD96 on CD8(+) T cells from PLWH is associated with decreased expression of the co-stimulatory receptors CD27 and CD28, higher expression of the senescence marker CD57 and accumulation of a terminally differentiated T-cell memory phenotype. In addition, we show that CD96-low CD8(+) T-cells display lower proliferative potential compared to their CD96-high counterparts and that loss of CD96 expression by HIV-specific CD8(+) T-cells is associated with a suboptimal response to HIV antigens. In conclusion, our results suggest that CD96 marks CD8(+) T-cells with competent responses to HIV and the loss of its expression might be used as a biomarker for CD8(+) T-cell senescence and dysfunction in PLWH. Frontiers Media S.A. 2021-05-27 /pmc/articles/PMC8190400/ /pubmed/34122431 http://dx.doi.org/10.3389/fimmu.2021.673061 Text en Copyright © 2021 Bunet, Nayrac, Ramani, Sylla, Durand, Chartrand-Lefebvre, Routy, Landay, Gauchat, Chomont, Ancuta, Kaufmann, Bernard, Tremblay and El-Far https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Bunet, Rémi Nayrac, Manon Ramani, Hardik Sylla, Mohamed Durand, Madeleine Chartrand-Lefebvre, Carl Routy, Jean-Pierre Landay, Alan L. Gauchat, Jean-Francois Chomont, Nicolas Ancuta, Petronela Kaufmann, Daniel E. Bernard, Nicole Tremblay, Cécile L. El-Far, Mohamed Loss of CD96 Expression as a Marker of HIV-Specific CD8(+) T-Cell Differentiation and Dysfunction |
title | Loss of CD96 Expression as a Marker of HIV-Specific CD8(+) T-Cell Differentiation and Dysfunction |
title_full | Loss of CD96 Expression as a Marker of HIV-Specific CD8(+) T-Cell Differentiation and Dysfunction |
title_fullStr | Loss of CD96 Expression as a Marker of HIV-Specific CD8(+) T-Cell Differentiation and Dysfunction |
title_full_unstemmed | Loss of CD96 Expression as a Marker of HIV-Specific CD8(+) T-Cell Differentiation and Dysfunction |
title_short | Loss of CD96 Expression as a Marker of HIV-Specific CD8(+) T-Cell Differentiation and Dysfunction |
title_sort | loss of cd96 expression as a marker of hiv-specific cd8(+) t-cell differentiation and dysfunction |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190400/ https://www.ncbi.nlm.nih.gov/pubmed/34122431 http://dx.doi.org/10.3389/fimmu.2021.673061 |
work_keys_str_mv | AT bunetremi lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction AT nayracmanon lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction AT ramanihardik lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction AT syllamohamed lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction AT durandmadeleine lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction AT chartrandlefebvrecarl lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction AT routyjeanpierre lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction AT landayalanl lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction AT gauchatjeanfrancois lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction AT chomontnicolas lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction AT ancutapetronela lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction AT kaufmanndaniele lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction AT bernardnicole lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction AT tremblaycecilel lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction AT elfarmohamed lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction |